Detalles de la búsqueda
1.
Synthesis and in vivo evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors.
Chem Pharm Bull (Tokyo)
; 62(12): 1200-13, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25450629
2.
YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors.
Clin Cancer Res
; 12(5): 1630-8, 2006 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16533791
3.
(+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
J Med Chem
; 49(2): 716-26, 2006 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-16420057
4.
YM-201627: an orally active antitumor agent with selective inhibition of vascular endothelial cell proliferation.
Cancer Lett
; 238(1): 119-27, 2006 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-16095812
5.
YM-231146, a novel orally bioavailable inhibitor of vascular endothelial growth factor receptor-2, is effective against paclitaxel resistant tumors.
Biol Pharm Bull
; 28(11): 2096-101, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16272696
Resultados
1 -
5
de 5
1
Próxima >
>>